Results 231 to 240 of about 94,345 (348)

Therapeutic targeting of the hepcidin-ferroportin axis and erythropoietic modulators: a narrative review. [PDF]

Front Med (Lausanne)
Mansour GK, Hajjar AW, Sajid MR.
europepmc   +1 more source

Single‐Position Peptide Clustering for Peptidomics Reveals Novel Disease Biomarkers and Dysregulated Proteolytic Characteristics

Advanced Science, Volume 13, Issue 5, 27 January 2026.
A novel amino acid (aa)‐score‐based single‐position peptide clustering strategy is developed for peptidomics, enabling precise profiling of protein proteolysis in plasma from β‐thalassemia cohort. The method identifies new aa position‐based peptide cluster biomarkers validated by heavy‐labeled peptides, visualizes aggregated changes, uncovers disease ...
Na Li, Yaxin Zhu, Yumeng Yan, Jifeng Wang, Lili Niu, Xiang Ding, Mengmeng Zhang, Zhensheng Xie, Tanxi Cai, Xiaojing Guo, Jianming Luo, Peng An, Xiangqian Guo, Fuquan Yang   +13 more
wiley   +1 more source

Procyanidin displayed a synergistic effect with roxadustat on renal anemia in mice. [PDF]

Front Pharmacol
Cui M, Wang Z, Shi J, Wu W, Tao J, Han Y, Yang Z, Luo J, Luo Y, An P, Sun M.   +10 more
europepmc   +1 more source

Red Blood Cell‐Derived Exosomal miR‐93‐5p Promotes Lung Cancer Progression through PTEN Suppression

Advanced Science, Volume 13, Issue 3, 14 January 2026.
Red blood cell (RBC)‐derived exosomal miR‐93‐5p is elevated in lung cancer patients and correlates with poor outcomes. Exosomal miR‐93‐5p suppresses PTEN in cancer cells, enhancing proliferation, migration, and invasion. In mouse models, therapeutic inhibition with ASO‐miR‐93 5p reduces tumor growth, highlighting a bidirectional tumor‐RBC‐tumor axis ...
Ning Li, Pushpa Dhilipkannah, Van K Holden, Ashutosh Sachdeva, Feng Jiang   +4 more
wiley   +1 more source

Harmonizing Iron Terminology and Nomenclature. [PDF]

Cureus
Nashwan AJ, Zakir B, Hawas Y, Yassin M.
europepmc   +1 more source

APPRISE Oncology Program for Erythropoiesis-Stimulating Agents

, 2010
Karen L. Hagerty
openalex   +1 more source

Staff Time and Motion Assessment for Administration of Erythropoiesis-Stimulating Agents: A Two-Phase Pilot Study in Clinical Oncology Practices [PDF]

, 2013
John Reitan, Arletta van Breda, Patricia K. Corey‐Lisle, Sanatan Shreay, Ze Cong, Jason C. Legg   +5 more
openalex   +1 more source

Cancer Manipulates Adjacent Adipose Tissue to Exploit Fatty Acids via HIF‐1α/CCL2/PPARα Axis: A Metabolic Circuit to Support Tumor Progression

Advanced Science, Volume 13, Issue 3, 14 January 2026.
Cancer cells drive adjacent adipose tissue to release fatty acids by secreting CCL2, which activates PPARα‐dependent lipolysis. The resulting fatty acid influx amplifies HIF‐1α/CCL2 signaling, establishing a positive feedback loop that fuels tumor growth.
Jeong‐Eun Yun, Jieun Seo, Jiwon Koh, Seock‐Ah Im, Ki Yong Hong, Yeseon Son, Do‐Won Jeong, Junji Fukuda, Jong‐Wan Park, Yang‐Sook Chun   +9 more
wiley   +1 more source

<p>Prolyl hydroxylase domain proteins: Localization, regulation, function and their role in erythropoiesis (Review)</p>. [PDF]

Mol Med Rep
Hou Y, Zhang ZH, Li WQ, Han GX, Shen K, Xie YB.   +5 more
europepmc   +1 more source

Preoperative Stimulation of Erythropoiesis in Patients with Anemia

, 2010
В. И. Загреков, A. V. Taranyuk, G. A. Maksimov, I. Yu. Yezhov   +3 more
openalex   +2 more sources